NCT02522611 2026-01-23
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
Clinical Trials
4 trialsNCT07008703 2025-06-06
Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1/2 Recruiting
NCT03146806 2021-09-09
Intranasal (NAS) Ketamine for Cancer Pain
Emory University
Phase 1/2 Completed
NCT00046709 2013-10-10
Marijuana for Cancer Pain
Center for Medicinal Cannabis Research
Phase 1/2 Terminated